Apparent Mineralocorticoid Excess
Oncology·MeSH: Ornithine Carbamoyltransferase Deficiency Disease
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Apparent Mineralocorticoid Excess?
There are 1 clinical trial targeting Apparent Mineralocorticoid Excess tracked by BioSniper.
What is the prevalence of Apparent Mineralocorticoid Excess?
The estimated prevalence of Apparent Mineralocorticoid Excess is approximately 0.1 per 100,000 population.
Deep-dive into Apparent Mineralocorticoid Excess
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis